###
中国临床研究:2026,39(8):1222-1226
本文二维码信息
码上扫一扫!
高、低剂量氨甲环酸输注对心脏手术患者炎症因子及凝血功能的影响
(新疆维吾尔自治区人民医院麻醉手术中心, 新疆 乌鲁木齐 830001)
Effects of high-dose versus low-dose tranexamic acid infusion on inflammatory factors and coagulation function in patients undergoing cardiac surgery
(Department of Anesthesia Surgery Center,People's Hospital of Xinjiang Uygur Autonomous Region,Urumqi,Xinjiang 830001,China)
摘要
本文已被:浏览 223次   下载 189次
投稿时间:2025-11-18   网络发布日期:2026-08-25
中文摘要: 目的 探讨高、低剂量氨甲环酸输注对心脏手术患者炎症因子、凝血因子及术后30 d主要不良事件的影响,为临床上氨甲环酸的应用提供参考。方法 前瞻性选择2022年12月至2025年3月于新疆维吾尔自治区人民医院择期行体外循环心脏手术患者67例,随机分为高剂量组(n=33)和低剂量组(n=34)。低剂量组氨甲环酸剂量为静脉负荷量10 mg/kg+静脉维持量2 mg/(kg·h)+体外循环预充量1 mg/kg,高剂量组氨甲环酸剂量为静脉负荷量30 mg/kg+静脉维持量16 mg/(kg·h)+体外循环预充量2 mg/kg。于患者麻醉诱导前(T1)、术后6 h(T2)、术后24 h(T3)检测炎性相关指标[包括白细胞计数(WBC)、白细胞介素(IL)-6、IL-10,肿瘤坏死因子-α(TNF-α)和C反应蛋白(CRP)]和凝血纤溶相关指标[包括凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(FIB)和血小板计数(PLT)],并记录术后30 d主要不良事件发生情况。结果 T2、T3时,高剂量组的CRP、IL-6、TNF-α水平显著低于低剂量组(P<0.05),IL-10 和WBC 两组间差异无统计学意义(P>0.05)。T2时,与低剂量组相比,高剂量组的PT更短[(12.57±2.49)s vs(14.26±1.65)s,P=0.002],FIB更高[(2.46±0.62)g/L vs(2.06±0.54)g/L,P=0.007]。高剂量组血小板计数术后保持稳定(P>0.05),而低剂量组显著下降(P<0.05)。术后30 d 随访期间,高剂量组发生肾功能不全3 例(9.09%),低剂量组发生肾功能不全1 例(2.94%),两组差异无统计学意义(P=0.606)。结论 在体外循环心脏手术中,高剂量氨甲环酸能更有效地抑制术后炎症反应并改善凝血功能,且并未增加术后30 d主要不良事件发生率,安全性良好。
Abstract:Objective To investigate the effects of high-dose and low-dose tranexamic acid infusion on inflammatory factors,coagulation indexes and major adverse events within 30 days after surgery in patients undergoing cardiac surgery,so as to provide evidence for clinical application of tranexamic acid. Methods A total of 67 patients scheduled for elective cardiac surgery with cardiopulmonary bypass(CPB)admitted to the People's Hospital of Xinjiang Uygur Autonomous Region from December 2022 to March 2025 were prospectively enrolled and randomly divided into the high-dose group(n=33)and the low-dose group(n=34). The low-dose group received an intravenous loading dose of 10 mg/kg,followed by maintenance infusion at 2 mg/(kg·h),plus 1 mg/kg added to CPB priming fluid. The high-dose group received an intravenous loading dose of 30 mg/kg,maintenance infusion at 16 mg/(kg · h),plus 2 mg/kg in CPB priming fluid. Inflammatory indicators including white blood cell count(WBC),interleukin (IL)-6, IL-10,tumor necrosis factor-α(TNF-α)and C-reactive protein(CRP),as well as coagulation and fibrinolysis parameters[prothrombin time(PT),activated partial thromboplastin time(APTT),thrombin time(TT),fibrinogen(FIB)and platelet count(PLT)]were detected before anesthesia induction(T1),6 h postoperatively(T2)and 24 h postoperatively(T3). The incidence of major adverse events within 30 days after surgery was recorded. Results At T2 and T3,the levels of CRP,IL-6 and TNF-α in the high-dose group were significantly lower than those in the low-dose group(P<0.05). No statistically significant intergroup differences were observed in IL-10 and WBC levels(P>0.05). At T2,compared with the low-dose group,the high-dose group exhibited shorter PT[(12.57±2.49)s vs(14.26±1.65)s,P=0.002]and higher FIB levels[(2.46±0.62)g/L vs(2.06±0.54)g/L,P=0.007]. Platelet counts remained stable in the high-dose group after surgery(P>0.05),whereas a significant decline was found in the low-dose group(P<0.05). During the 30-day postoperative follow-up,renal insufficiency occurred in 3 patients(9.09%)in the high-dose group and 1 patient(2.94%)in the low-dose group,without statistically significant difference between the two groups(P=0.606). Conclusion For cardiac surgery with cardiopulmonary bypass,high - dose tranexamic acid can more effectively inhibit postoperative inflammatory response and improve coagulation function,without increasing the incidence of major adverse events within 30 days after surgery,showing a favorable safety profile.
文章编号:     中图分类号:R614.2    文献标志码:A
基金项目:“天山英才”医药卫生高层次人才培养计划项目(TSYC202301B007);新疆科技支疆项目(2022E02116)
附件
引用文本:
闫磊, 麦尔哈巴·艾尼, 古文玉, 地里娜尔·吐尔洪.高、低剂量氨甲环酸输注对心脏手术患者炎症因子及凝血功能的影响[J].中国临床研究,2026,39(8):1222-1226.

用微信扫一扫

用微信扫一扫